Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +16

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Teresa A. Soucy, Peter G. Smith, Michael A. Milhollen et al. · Nature · 2009 · 2K citations

Medicine, Medicinal Chemistry, Oncology +8

The cellular thermal shift assay for evaluating drug target interactions in cells

Rozbeh Jafari, Helena Almqvist, Hanna Axelsson et al. · Nature Protocols · 2014 · 1.5K citations

Medicine, Cell Biology, Pharmacology +13

Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells

Mónica L. Guzmán, Sarah J. Neering, Donna Upchurch et al. · Blood · 2001 · 757 citations

Medicine, Cell Biology, Oncology +7

The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule

Benedict C. S. Cross, Peter J. Bond, Paweł Sadowski et al. · Proceedings of the National Academy of Sciences · 2012 · 594 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17